ICCBBA has published a new technical bulletin, TB-016 Improving Quality of Care through Traceability, to describe how the use of ISBT 128 facilitates the inclusion of product identifiers into patient electronic health records.  Developments described within this document would have an immediate beneficial impact on traceability and would facilitate the electronic exchange of health information to improve quality of care for patients around the world.

This document helps users recognize various labeling scenarios that may apply to cellular therapy products.